4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine
C37H32N3O+ — CID 155614502
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine
4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine (PubChem CID 155614502) has the molecular formula C37H32N3O+ and a molecular weight of 534.68 g/mol. Its IUPAC name is 4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine.
Molecular Properties
| Compound Name | 4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine |
|---|---|
| PubChem CID | 155614502 |
| Molecular Formula | C37H32N3O+ |
| Molecular Weight | 534.68 g/mol |
| Exact Mass | 534.25 |
| IUPAC Name | 4-tert-butyl-2-[9-[3-(1H-imidazol-3-ium-3-yl)phenyl]fluoren-9-yl]-6-phenoxypyridine |
| SMILES | CC(C)(C)c1cc(Oc2ccccc2)nc(C2(c3cccc(-[n+]4cc[nH]c4)c3)c3ccccc3-c3ccccc32)c1 |
| InChI | InChI=1S/C37H31N3O/c1-36(2,3)27-23-34(39-35(24-27)41-29-14-5-4-6-15-29)37(26-12-11-13-28(22-26)40-21-20-38-25-40)32-18-9-7-16-30(32)31-17-8-10-19-33(31)37/h4-25H,1-3H3/p+1 |
| InChIKey | RBXSDMNJAIKEBL-UHFFFAOYSA-O |
| XLogP | 8.14 |
| TPSA | 41.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 534.68 |
| LogP ≤ 5 | 8.14 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155614502 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.